Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer-Reference-Cited by-同舟云学术

Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

Published:2023 Issue:2 Volume:26 Page:105
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Kim Min Chong¹^ORCID,Kwon Sun Young²^ORCID,Choi Jung Eun³^ORCID,Kang Su Hwan³^ORCID,Bae Young Kyung¹^ORCID

Affiliation:

1. Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea.

2. Department of Pathology, Keimyung University School of Medicine, Daegu, Korea.

3. Department of Surgery, Breast Cancer Center, Yeungnam University College of Medicine, Daegu, Korea.

Publisher

XMLink

Subject

Cancer Research,Oncology

Link

https://ejbc.kr/pdf/10.4048/jbc.2023.26.e19

Reference36 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

3. National Comprehensive Cancer Network (NCCN). NCCN Guidelines: Breast Cancer. 2022. Accessed January 27th, 2023. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf

4. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

5. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer;Breast Cancer;2024-07-17

2. Development and validation of a clinical breast cancer tool for accurate prediction of recurrence;npj Breast Cancer;2024-06-15

3. Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective;The Breast;2024-06

4. Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence;Cancers;2024-05-23

5. The added value of ultrasound imaging biomarkers to clinicopathological factors for the prediction of high-risk Oncotype DX recurrence scores in patients with breast cancer;Quantitative Imaging in Medicine and Surgery;2024-05